<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Pharmaceutical Companies]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/pharmaceutical-companies</link>
    <description><![CDATA[Pharmaceutical Companies]]></description>
    <pubDate>Thu, 18 Jun 2026 06:01:26 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[2025 Exelixis Business Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry]]></title>
      <link>https://www.leadingmarketresearch.com/2025-exelixis-business-review-and-outlook-strategic-swot-analysis-perform</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
<p>The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-233963"><span class="price">$750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 03 Jun 2025 20:25:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2025 Abbvie Business Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry]]></title>
      <link>https://www.leadingmarketresearch.com/2025-abbvie-business-review-and-outlook-strategic-swot-analysis-performan</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
<p>The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-233957"><span class="price">$750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 03 Jun 2025 20:25:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2025 Alnylam Pharmaceuticals Business Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry]]></title>
      <link>https://www.leadingmarketresearch.com/2025-alnylam-pharmaceuticals-business-review-and-outlook-strategic-swot-an</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
<p>The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-233959"><span class="price">$750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 03 Jun 2025 20:25:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2025 Virbac Business Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry ]]></title>
      <link>https://www.leadingmarketresearch.com/2025-virbac-business-review-and-outlook-strategic-swot-analysis-performan</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
<p>The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-233956"><span class="price">$750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 03 Jun 2025 20:25:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2025 Alexion Pharmaceuticals Business Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry]]></title>
      <link>https://www.leadingmarketresearch.com/2025-alexion-pharmaceuticals-business-review-and-outlook-strategic-swot-an</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
<p>The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-233958"><span class="price">$750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 03 Jun 2025 20:25:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2025 Zoetis Business Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry]]></title>
      <link>https://www.leadingmarketresearch.com/2025-zoetis-business-review-and-outlook-strategic-swot-analysis-performan</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
<p>The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-233955"><span class="price">$750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 03 Jun 2025 20:25:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pfizer Inc. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/pfizer-inc-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Pfizer Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Pfizer Inc. (Pfizer) is a research-driven biopharmaceutical company that focuses on the discovery, development, manufacturing, marketing, selling, and distribution of medicines and vaccines. Its products cover a broad spectrum of therapeutic areas, including anti-infectives, oncology, cardiovascular health, diabetes, obesity, inflammation, immunology, rare diseases, and bacterial infections. Pfizer also offers contract manufacturing services to other pharmaceutical companies. Healthcare providers, hospitals, clinics, and pharmacies utilize its products to manage various medical conditions. Pfizer distributes products through a network of wholesalers, retailers, and government agencies through brands such as Zavzpret, Abrysvo, Inflectra, Genotropin, Octagam, and ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-235426"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Sat, 21 Jun 2025 19:52:45 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[ALK-Abello AS. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/alk-abello-as-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>ALK-Abello AS. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>ALK-Abello AS. (ALK-Abello or &#039;the company&#039;) is a pharmaceutical company that develops and markets allergy treatment products in the form of injections, sublingual drops, and sublingual tablets. It also produces an adrenaline auto-injector for the treatment of severe allergic reactions (anaphylaxis) and also manufactures products used in the diagnosis of allergies. The company&#039;s SLIT tablets cover the five common respiratory allergies, including grass, house dust mite, Japanese cedar, ragweed, and tree for children, adolescents, and adults. It has a business presence across Europe, North America, and other parts of the world. The company is headquartered in Horsholm, Denmark.<br><br><b>Scope</b><br><br>- Detailed information on ALK-Abello AS. r...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234812"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Baxter International Inc. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/baxter-international-inc-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Baxter International Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Baxter International Inc. (Baxter or &#039;the company&#039;) is a provider of range of healthcare products across portfolio of acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, generic injectable pharmaceuticals, inhaled aesthetics, parenteral nutrition therapies, and surgical haemostat and sealant products. The company provides these products to hospitals, nursing homes, kidney dialysis centres, rehabilitation centers, doctors&#039; offices and to patients under the supervision of general physician. It sells the products through direct sales force and through independent distributors, drug wholesalers acting as sales agents and specialty pharmacy or other alternate site providers. Baxter has o...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234814"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Brookdale Senior Living, Inc. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/brookdale-senior-living-inc-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Brookdale Senior Living, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Brookdale Senior Living, Inc. (Brookdale or &#039;the company&#039;) is a provider of senior living housing and related services. The company offers services such as independent living, memory care, skilled nursing, assisted living, and continuing care retirement communities. Its comprehensive network help seniors with care and services. Brookdale&#039;s independent living communities offers residents to choose from studio, one-bedroom, and two-bedroom units and provides with basic services such as 24-hour assistance, dining service options, an emergency alert system, housekeeping, education and wellness programs, and recreational activities. The company operates communities through direct and third-party service providers. The company is headq...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234815"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Charles River Laboratories International, Inc. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/charles-river-laboratories-international-inc-company-profile-and-swot-a</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Charles River Laboratories International, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Charles River Laboratories International, Inc. (CRL or &#039;the company&#039;) is a full service, early-stage contract research organization. Its core competencies and research model technologies allow it to develop a range of discovery and safety assessment services in both GLP and non-GLP standards. The company also provides various services related to clients manufacturing activities including contract development and manufacturing organization business. These include basic research services drug discovery and safety assessment services, operations and staffing support services, clinical support services, and manufacturing support services (endotoxin and microbial detection, biologics testing solutions, and avian vaccine se...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234816"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cipla Limited - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/cipla-limited-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Cipla Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Cipla Limited (Cipla or &#039;the company&#039;) is a manufacturer of prescription drugs, veterinary and active pharmaceutical ingredient products. The company provides products for various therapeutic categories including dermatology, critical care, cardiovascular, infectious diseases, children&#039;s health, and cosmetology, HIV/AIDS, diabetes, neurosciences, hepatitis, malaria, oncology, ophthalmology, respiratory, osteoporosis and urology. It also manufactures metered-dose inhaler devices, spacers and related devices. Cipla is engaged in biosimilar and consumer healthcare. Cipla operates manufacturing facilities in multiple locations across the world. Cipla offers its products in South Africa, India, and North America, and other markets. The company is hea...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234817"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[CSL Limited - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/csl-limited-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>CSL Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>CSL Limited (CSL or &#039;the group&#039;) is a provider of biotherapies. The group&#039;s products are used to treat and prevent serious and rare medical conditions. The group operates globally through its human health businesses that include the operations of CSL Behring, CSL Plasma and Seqirus. Seqirus provides in-licensed vaccines and specialty pharmaceuticals in Australia and New Zealand. It operates in various therapeutic areas including immunology, haematology, cardiovascular and metabolic, respiratory, and transplant. The group supplies range of products for the Australian Government. It offers products in Germany, Australia, the UK, Switzerland, the US and rest of the world. The group is headquartered in Melbourne, Victoria, Australia.<br><br><b>Scope</...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234818"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Dr. Reddy&#039;s Laboratories Limited - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/dr-reddy-039-s-laboratories-limited-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Dr. Reddy&#039;s Laboratories Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Dr. Reddy&#039;s Laboratories Limited (DRL or &#039;the company&#039;) is a manufacturer of generics, active pharmaceutical ingredients (APIs), and proprietary products. The generics products are ready for consumption by the customer product and specified for the areas of gastrointestinal, cardiovascular, pain management, oncology, anti-infectives, respiratory and nervous system. The company&#039;s pharmaceutical services offer end-to-end product development and manufacturing services and solutions to innovator companies. DRL is engaged in the discovery of new chemical entities for the areas of metabolic disorders, pain and inflammation. It operates in India, North America, Europe, Russia Commonwealth of independent states (CIS) countri...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234819"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[H. Lundbeck A/S - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/h-lundbeck-a-s-company-profile-and-swot-analysis-235179</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>H. Lundbeck A/S - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>H. Lundbeck A/S (Lundbeck or &#039;the company&#039;) is engaged in research, development, production and sale of pharmaceuticals mainly concentrating on central nervous system (CNS) disorders. The company&#039;s products are focused on treating depression/anxiety, Alzheimer&#039;s disease, schizophrenia, alcohol dependence, Parkinson&#039;s disease, epilepsy, Lennox-gastaut syndrome, Huntington&#039;s disease, psychotic disorders, symptomatic neurogenic orthostatic hypotension, and bipolar disorders. Lundbeck markets its products under Abilify Maintena, Azilect, Brintellix, Celexa, Cipralex, Cipramil, Cisordinol, Deanxit, Ebixa, Lexapro, Northera, Onfi, Rexulti, Sabril, Trintellix, and Xenazine brands names. Its largest markets are Australia, China, Brazil,...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234820"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Henry Schein, Inc. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/henry-schein-inc-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Henry Schein, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Henry Schein, Inc. (Henry Schein or &#039;the company&#039;) is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The company offers consumable products, small equipment, laboratory products, large equipment, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The company also provides technology solutions, including practice management software, e-commerce solutions and a range of financial services. The company also serves dental laboratories, office-based dental practitioners, schools and other institutions, ambulatory surgery centers, other alternate-care settings and other institutions. It has business presence across the ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234821"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Hikma Pharmaceuticals PLC - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/hikma-pharmaceuticals-plc-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Hikma Pharmaceuticals PLC - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Hikma Pharmaceuticals PLC (Hikma or &#039;the company&#039;) is a manufacturer, developer and marketer of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various forms such as injectable, oral and other non-injectable generic products. Its major customers in the US and Europe include pharmacy chains, wholesalers, governments, and hospital purchasing organizations. Hikma markets products to doctors and pharmacists in Middle East and North Africa region through its representatives. The company prima...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234822"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/ionis-pharmaceuticals-inc-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Ionis Pharmaceuticals, Inc. (Ionis or &#039;the company&#039;) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer&#039;s, Huntington&#039;s, and Parkinson&#039;s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington&#039;s disease. Ionis uses antisense technology in the development of its drugs. It primarily...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234823"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Sigma Healthcare Limited - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/sigma-healthcare-limited-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Sigma Healthcare Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Sigma Healthcare Limited (Sigma or &#039;the company&#039;) is a wholesaler and distributor of pharmaceutical products and services. It offers a portfolio of services across the healthcare sector including hospital pharmacy services, retail pharmacy services, and supply and logistics services. The company sells a range of healthcare products, vitamins, medicine, baby care products, beauty products, toiletries and household products through its drug stores. Sigma provides services such as professional services program, financial services, pharmacy operations, tools and resources, rewards program and store performance analysis support. It also provides distribution, dose administration aid solutions and supply network and logistics. It operates stores...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234824"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Teva Pharmaceutical Industries Limited - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/teva-pharmaceutical-industries-limited-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Teva Pharmaceutical Industries Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Teva Pharmaceutical Industries Limited (Teva or &#039;the company&#039;) is a generic pharmaceutical company. The company develops, manufactures and markets generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. It offers specialty medicines for the treatment of cancer respiratory, disorders of the central nervous system (CNS) and women&#039;s health and other therapy areas. It offers a wide range of generic medicines in various forms including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. The company also provides over-the-counter (OTC) products. It conducts its operations primarily in the Americas, Europe, and Asia. The company is headquartered in Petach Tikva, Israel.<br><br>...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234825"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The University of Texas MD Anderson Cancer Center - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/the-university-of-texas-md-anderson-cancer-center-company-profile-and-swo</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>The University of Texas MD Anderson Cancer Center - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>The University of Texas MD Anderson Cancer Center (MD Anderson or &quot;the organization&quot;) is a cancer care centers in the US. The organization offers radiation oncology, surgical oncology and medical oncology services. It also provides several treatment support services, which include cancer pain management, genetic counseling, oncology nurse navigator services, on-site outpatient lab services, access to clinical trials, rehabilitation therapy, clinical nutrition, and plastics and reconstructive surgery. The company also provides treatment options for various types of cancers such as, ovarian cancer, fallopian tube cancer, cervical cancer, primary peritoneal cancer, vulvar cancer, gestational trophoblastic disease, pre...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234826"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Eurofins Scientific SE - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/eurofins-scientific-se-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Eurofins Scientific SE - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Eurofins Scientific SE (Eurofins or &#039;the company&#039;) is a life sciences company that is primarily involved in providing a range of analytical testing services to its clients across multiple industries. It offers REACH services, food, and feed testing services, genomic services, and pharma services. Eurofins provides analytical methods to assess the safety and authenticity of a diverse range of substances and biological products. The company minimizes dioxins, persistent organic pollutants, pesticides, heavy metals, and chemical containments through food and environmental testing. Eurofins also offers environmental testing such as water testing, air testing, pollution testing, and soil testing. It has operations across the Americas, Europe, and...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234827"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Les Laboratoires Servier - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/les-laboratoires-servier-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Les Laboratoires Servier - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Les Laboratoires Servier SAS (Servier) conducts drug research, development, manufacturing, and marketing of medicines and generic drugs. The company also offers therapeutic solutions to address unmet medical needs in the areas of cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, oncology and diabetes. Servier manufactures generics through its independent subsidiaries including Biogaran, Egis, and Pharlab. Its products are catered to various brands such as Procoralan, Natrilix, Triplixam, Natrixam, Triveram, Viacoram, Carivalan, Preterax, Viacorlix, Implicor, Cosyrel, Hyperium, Euvascor, Diamicron, Lipocomb, Valdoxan, Stablon, and Trivastal. It has operations in various geographical regions including the Americas, Europe, t...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234828"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Lonza Group Ltd - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/lonza-group-ltd-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Lonza Group Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Lonza Group Ltd (Lonza or &#039;the group&#039;) is a supplier of pharmaceutical products. Its products portfolio includes capsules and health ingredients, nutritional ingredients, small molecules, biologics. Lonza also provides clinical supply, integrated product design, development, and commercial manufacturing services to its customers across the world. The group&#039;s major markets include nutrition, pharma and biotech, materials science, microbial control, personal care, and bioresearch industries. It operates manufacturing and R&D facilities across Europe, Asia and the Americas. The group operates in Europe, North America, Latin America, Asia, Africa and other regions of the world. The group is headquartered in Basel, Switzerland.<br><br><b>Scope</b><...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234829"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Olympus Corporation - Company Profile and SWOT Analysis]]></title>
      <link>https://www.leadingmarketresearch.com/olympus-corporation-company-profile-and-swot-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Olympus Corporation - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company&#039;s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.<br><br>Key Highlights<br><br>Olympus Corporation (Olympus or &#039;the company&#039;) is involved in the manufacturing and marketing of precision machineries and devices for medical, imaging, life science and industrial applications. The company provides several products such as video endoscopy systems, gastrointestinal endoscopes, colon endoscopes, industrial fiberscopes, and life science imaging software. Its offerings also include virtual slide systems, bio-imaging systems, capsule endoscope systems, reprocessing products for cleaning, disinfection, and sterilization. It also provides microscopic 3D measurement instruments, and industrial microscope ancillary equipment, stereo microscopes, digital camera accessories, software and applications, lens barrel units and binoculars amo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-234830"><span class="price">$175.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 20 Jun 2025 13:57:26 +0000</pubDate>
    </item>
  </channel>
</rss>
